Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole for idiopathic restless legs syndrome and sleep disturbance
2005-005225-54Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in restless legs syndrome (RLS) comparing Pramipexole with Placebo (2 arms). Primary endpoints: Change from baseline in International Restless Legs Syndrome Study Group Rating Scale total score and Sleep disturbance on MOS sleep scale. Started May 2006; status: completed.
02
Drugs
pramipexole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2005-005225-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005225-54.